MRC2 and central nervous system cancer: In silico analyses of independent gene expression datasets in ONCOMINETM [19], [20], [21], [22], [23] revealed that Endo180 (MRC2) transcripts were significantly upregulated in grade IV gliomas, i.e. GBMs, versus grade III gliomas (Figure 1A).